StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
MADAME-R.BK$0.48+0.00%
Fair $0.48+0.0%

MADAME-R.BK

Madame Bioscience Public Company Limited

Consumer Defensive / Packaged FoodsThailand

$0.48

+0.00 (+0.00%)

Fairly Valued+0.0%Fair Value $0.48Fund rank 25/100 · Data gapFallback financials|
SA 42/C
F-Score: 6/9
Declining Revenue

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 17%

FCF escenarios

weak_data · normalized FCF $32.4M · quality 40.7/100

Data gap 25/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 14/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

42/100

C

Piotroski

6/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. Revenue has declined for 2 consecutive years
Thesis & Journal · MADAME-R.BKLocal privado en este navegador · Madame Bioscience Public Company Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$388M

P/E

8.0x

↓

EV/EBITDA

2.5x

↓

ROE

6.1%

↓

Gross Margin

21.8%

↓

Debt/Equity

0.33

↓
52-Week Range$0
$1$1

TradingView lightweight chart

MADAME-R.BK price, volumen y niveles de valoración

Último $0.950Periodo -41.4%
Fair value: $0.480

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-12.8%

FCF CAGR

—

FCF margin

-0.3%

FCF / Net income

-0.10x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $1.48B · net income $45.8M · FCF $-4.6M

2022-FY → 2025-FY

Gross margin

21.8%+18.1% pts

Operating margin

-14.2%+4.7% pts

Net margin

3.1%+22.1% pts

FCF margin

-0.3%+13.5% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$1.48B$1.48B$2.12B$2.30B$2.23B
Net Income$45.8M$45.8M$-331.6M$-405.8M$-422.3M
EBITDA$179.7M$179.7M$-186.9M$-240.7M$-310.0M
EPS0.060.06-0.54-0.66-0.70
Gross Margin21.8%21.8%17.0%12.9%3.7%
Operating Margin-14.2%-14.2%1.3%-7.8%-18.8%
Net Margin3.1%3.1%-15.6%-17.6%-19.0%
Balance Sheet
Debt/Equity0.330.331.231.110.81
Current Ratio1.411.41———
Cash Flow
Free Cash Flow$-4.6M$-4.6M$211.6M$32.4M$-307.5M
Returns
ROE6.1%6.1%-66.3%-55.0%-36.9%
Valuation
P/E8.008.00———
EV/EBITDA2.472.47———
P/B0.500.501.241.791.73
Growth & Yield
Revenue Growth-30.4%-30.4%-7.8%3.3%—
EPS Growth111.2%111.2%18.9%6.4%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

-10.8%

fácil

EPS terminal req.

$0.04

Spread vs growth

122.0%

5Y implied EPS CAGR

-3.0%

fácil

EPS terminal req.

$0.05

Spread vs growth

114.2%

10Y implied EPS CAGR

3.3%

fácil

EPS terminal req.

$0.08

Spread vs growth

107.9%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +26.7%

Total return

+26.7%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.54 → 0.06

Residual

+26.7%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term+26.7%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.